Key indicators: single-crystal X-ray study; T = 100 K; mean (C-C) = 0.012 Å; R factor = 0.092; wR factor = 0.167; data-to-parameter ratio = 7.0.
The title compound, C 19 H 28 O 4 , was prepared from DHEA (dehydroepiandrosterone) by its biotransformation using whole cells of the filamentous fungus Beauveria bassiana. The asymmetric unit contains two molecules. The lactone ring is trans-positioned to the neighboring six-membered ring. In the crystal structure, O-HÁ Á ÁO hydrogen bonds form layers, which are linked to each other by O-HÁ Á ÁO and C-HÁ Á ÁO hydrogen bonds.
Related literature
For background information on steroidal lactones and their properties, see: Braunstein (1999) ; Brodie & Njar (1998) ; Bydal et al. (2009) ; Feuillan et al. (1999) ; Li & Parish (1996) ; Dunkel (2006) ; Penov Gaši et al. (2001 Gaši et al. ( , 2005 . For the general method of preparation of the title compound, see: Kołek et al. (2008) . Mo K radiation = 0.09 mm À1 T = 100 K 0.12 Â 0.08 Â 0.07 mm
Data collection
Kuma KM-4 CCD diffractometer 8286 measured reflections 2921 independent reflections 2062 reflections with I > 2(I) R int = 0.118 Refinement R[F 2 > 2(F 2 )] = 0.092 wR(F 2 ) = 0.167 S = 1.13 2921 reflections 415 parameters 1 restraint H-atom parameters constrained Á max = 0.26 e Å À3 Á min = À0.28 e Å À3 Table 1 Hydrogen-bond geometry (Å , ). Symmetry codes: (i) x þ 1; y À 1; z; (ii) Àx þ 1; y À 1 2 ; Àz þ 2; (iii) Àx þ 2; y À 1 2 ; Àz þ 1; (iv) Àx þ 2; y þ 1 2 ; Àz þ 1; (v) x À 1; y; z.
Data collection: CrysAlis CCD (Oxford Diffraction, 2009); cell refinement: CrysAlis RED (Oxford Diffraction, 2009 ); data reduction: CrysAlis RED; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008) ; program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: XP (Bruker, 1999) ; software used to prepare material for publication: SHELXL97.
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resent compounds with promising potency towards human aromatase inhibition (Penov Gaši et al., 2001 , 2005 . Testolactone (17a-oxa-D-homo-androsta-1,4-diene-3,17-dione) is used as a pharmaceutical agent in disorders caused by imbalance between estrogen and androgen action, e.g. gynecomastia (Braunstein, 1999) or precocious puberty (Feuillan et al., 1999; Dunkel, 2006) .
As a part of our ongoing investigation of the biosynthesis of steroidal lactones, the title compound was obtained.
There are two molecules of the title compound in the asymmetric unit ( Fig. 1 ). O11-H11···O17(-x + 1, y -1/2, -z + 2) hydrogen bonds are found, also O3A-H31A···O11a(-x + 2, y -1/2, -z + 1) hydrogen bonds, resulting in chains extended along the [010] direction ( Table 1) 
Experimental
The title compound was prepared from DHEA (dehydroepiandrosterone) by its biotransformation using whole-cells of filamentous fungus Beauveria bassiana, according to the general procedure described in (Kołek et al., 2008) . The crude extract of reaction products was subjected to silica gel column chromatography using a mixture of ethyl acetate/dichloromethane/ acetone/2-propanol (3:1:0.5:0.15) as eluent. The product of this biotransformation was identified by interpretation of its IR, 1 H NMR and 13 C NMR spectroscopic data. 1 H-NMR: δ (p.p.m.) in CD 3 OD: 1.20 (s, 19-H3); 1.38 (s, 18-H3); 3.45 (m, 3α-H); 3.88 (m, 11β-H); 5.46 (d, J = 5.7 Hz); 13 C-NMR: δ (p.p.m.) in CD3OD: 174.4 (C-17); 142.7 (C-5); 121.4 (C-6); 83.6 (C-13); 72.5 (C-3); 69.0 (C-11); 56.9 (C-9); 50.3 (C-12); 47.0 (C-14); 43.3 (C-4); 40.4 (C-1); 39.5 (C-10), 35.5 (C-2); 32.3 (C-7); 32.2 (C-8); 29.4 (C-16); 21.1 (C-18); 20.8 (C-15); 19.2 (C-19); IR ν max (cm -1 ): 3440, 1716. Single crystals of the title compound, suitable for X-ray diffraction analysis, were obtained by slow evaporation from methanol after two weeks at room temperature.
Refinement
All H atoms bonded to O atoms were located in a difference map and then placed in idealised calculated positions with O-H distances of 0.84 Å. All H atoms bonded to C atoms were placed in calculated positions with C-H distances of supplementary materials sup-2 0.95 -1.00 Å. All H atoms were refined as riding. In the absence of significant anomalous scattering, Friedel pairs were merged. The absolute configuration of the title compound was assigned on the basis of the known absolute configuration of particular substrates (commercially available) Figures   Fig. 1 . A view of the two crystallographically unrelated 3β,11α-dihydroxy-17a-oxa-D-homoandrost-5-en-17-one molecules together with the numbering scheme employed (30% probability displacement parameters). (7) C2A-C1A-C10A 115.0 (7) C10-C1-H1A 108.9 C2A-C1A-H1C 108.5 C2-C1-H1A 108.9 C10A-C1A-H1C 108.5
Hydrogen-bond geometry (Å, °) 
